Gary J. Palmer bought Gilead Sciences Inc (NASDAQ: GILD)
Gary J. Palmer (R-AL), a U.S. Representative, has disclosed 1 trade in Gilead Sciences Inc (GILD) since 2017, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Gary J. Palmer bought $1,001 - $15,000 of Gilead Sciences Inc (NASDAQ: GILD) on April 4, 2017. Since that trade, GILD is up +171.94% against the S&P 500 up +263.24%, an outperformance of -91.30%.
Data updated
Gary J. Palmer's GILD trades vs the price
GILD is up +171.94% since Gary J. Palmer bought on April 4, 2017, versus +263.24% for the S&P 500.
Performance since this trade
All Gary J. Palmer GILD trades
Gary J. Palmer & GILD trading FAQ
Is it legal for Gary J. Palmer to trade Gilead Sciences Inc (GILD) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Gilead Sciences Inc (GILD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Gary J. Palmer buy GILD?
Gary J. Palmer disclosed a purchase of $1,001 - $15,000 of Gilead Sciences Inc (GILD) on April 4, 2017, according to public STOCK Act filings.
How has GILD performed since Gary J. Palmer's trade?
Since Gary J. Palmer bought GILD on April 4, 2017, the stock is up +171.94%, versus +263.24% for the S&P 500 over the same period, an outperformance of -91.30%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional GILD trades?
Quantellect tracks every disclosed congressional trade in Gilead Sciences Inc (GILD) on the Gilead Sciences Inc congressional trading page, which aggregates filings across all members of Congress.
Gary J. Palmer's GILD tradesAll congressional filings for Gilead Sciences IncGary J. Palmer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.